Skip to main content
Figure 4 | BMC Cancer

Figure 4

From: Cost-effectiveness analysis of adjuvant chemotherapies in patients presenting with gastric cancer after D2 gastrectomy

Figure 4

A tornado diagram representing the net health benefits (in QALYs with WTP = $6,100). The diagram was determined by a one-way sensitivity analysis of the XELOX strategy vs. surgery only for patients presenting with gastric cancer. The vertical line represents the base-case value for the net health benefit with WTP = $6,100. Key: RFS (relapse-free survival); OS (overall survival); HR (hazard ratio).

Back to article page